{"id":"W2973437633","doi":"10.1016/s0140-6736(19)31881-1","title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":1479,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Dupilumab; Nasal polyps; Placebo; Internal medicine; Placebo-controlled study; Sinusitis; Clinical endpoint; Randomized controlled trial; Asthma; Chronic rhinosinusitis; Surgery; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}